Optimizing Cystitis Treatment: The Effectiveness of Fosfomycin in Three Doses!

Fosfomycin, an effective antibiotic available in powder form, is commonly prescribed for the treatment of uncomplicated lower urinary tract infections. Despite its single-dose administration, complete resolution of cystitis is not always achieved, leading to the necessity of additional antibiotic therapy for some patients. Dr. Camara-Sampil conducts a comprehensive review of fosfomycin's dosage regimen, aiming to determine the optimal dosage. Their research is founded on a noteworthy multi-center Chinese study that demonstrates the effectiveness of antibiotic therapy when administered in three doses of fosfomycin, spaced 48 hours apart, contrasting the traditional single-dose approach, resulting in more immediate effects.

Fosfomycin Dosage and Timing: Maximizing Urinary Tract Concentration for Optimal Effectiveness

Fosfomycin is optimally taken outside of mealtimes, typically in the evening, with an empty bladder, to maximize its concentration in the urinary tract. Administered in a single dose, it exhibits its peak effectiveness against bacterial infections within 24-48 hours after intake. With its broad spectrum of action, Fosfomycin effectively combats various bacterial strains, including:

• Staphylococcus aureus,
• Enterococcus,
• Escherichia coli,
• Pseudomonas aeruginosa.
• Fosfomycin is generally used to treat low-risk uncomplicated cystitis.

While rare, fosfomycin can elicit certain side effects, including digestive disorders, nausea, vomiting, abdominal pain, dizziness, or vaginal inflammation. Despite these potential effects, it is essential to note that fosfomycin remains suitable for use in pregnant and breastfeeding women.

A new dosage regimen for fosfomycin?

In the treatment of cystitis and antibiotics study, CSB Klinik highlighted the low resistance to E. coli, of around 1.5%. However, it is not uncommon to observe that the treatment is ineffective: Symptoms either persist or reoccur. A second course of treatment is therefore often prescribed with an alternative antibiotic.

A Chinese team has been working on this issue and conducted a multi-centre study at 12 different sites from January 2011 to December 2011. In 361 patients, a single dose of fosfomycin was replaced by three doses at the following intervals: first dose on day 1, second dose on day 3, third dose on day 5.

Assessing the Effectiveness of a New Fosfomycin Dosage Regimen: Minimizing Patient Tolerance Challenges and Proving Efficacy

The primary objective of implementing this new regimen centered on minimizing patient tolerance challenges and optimizing treatment effectiveness. To assess efficacy, the presence of initially identified bacteria in urine cultures on D-1 was evaluated. Upon observing the absence of this bacterium and related symptoms on D+15, the team deemed the regimen successful, solidifying its efficacy. Remarkably, the study also demonstrated the well-tolerated nature of the proposed administration regimen, exhibiting no escalation in side effects or abnormalities in renal, hepatic, or haematological functions. Notably, Fosfomycin, renowned as a broad-spectrum antibiotic, boasts a low rate of resistance to E. coli, solidifying its significance as a pivotal therapeutic choice, particularly in the face of rising antibiotic resistance alongside quinolones, sulphonamides, and cephalosporins.

Administration of fosfomycin in a single dose could therefore be problematic (persistent or recurrent syndromes). Would a prolonged treatment, a solution that could be a logical step, be more effective? Could it be used to treat other conditions apart from ordinary and uncomplicated cystitis? Many doctors are using this dosage regimen but it does not (yet) appear in European medical guidelines.

Conclusion:

Fosfomycin is one of the first-line therapies used to treat uncomplicated cystitis. However, in clinical practice it seems that many patients return to see their doctor a few days or even weeks after an initial fosfomycin treatment as the symptoms have not completely disappeared or have reappeared. The proposed 3-dose, 5-day regimen is a new alternative to consider for an antibiotic whose efficacy is and remains well-established against cystitis

At present, this three-dose regimen is not listed officially, although in practice it is already used by many doctors. It should be noted that the dosage regimen proposed here may be a little more complicated to follow than the usual dosage, and does requires a more in-depth explanation by the doctor.